Prosecution Insights
Last updated: April 19, 2026

Msn Laboratories Private Limited R & D Center

1 pending office actions

Portfolio Summary

1
Total Pending OAs
0
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17918911 PHARMACEUTOCAL COMPOSITION CONTAINING N-(4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-N?-(4­FLUOROPHENLY)CYCLOPROPANE-1,1-DICARBOXAMIDE, (2S)-HYDROXYBUTANEDIOATE LADD, CAROLYN LOUISE 1622 Non-Final OA Oct 14, 2022

Managing Msn Laboratories Private Limited R & D Center's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month